{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:15:49Z","timestamp":1791400549361,"version":"4.3.3"},"reference-count":49,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T00:00:00Z","timestamp":1240963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nuclear factor\u2010\u03baB (NF\u2010\u03baB) is a pleiotropic transcription factor that generally enhances cellular resistance to apoptotic cell death. It has been shown to be constitutively active in some cancers and is being pursued as potential anticancer target. Sulfasalazine which is used clinically to treat Crohn\u2019s disease has emerged as a potential inhibitor of NF\u2010\u03baB and has shown promising results in two pre\u2010clinical studies to target primary brain tumors, gliomas. Once digested, sulfasalazine is cleaved into sulfapyridine and 5\u2010aminosalicylic acid (5\u2010ASA; mesalamine) by colonic bacteria, and the latter, too, is reported to suppress NF\u2010\u03baB activity. We now show that glioma cells obtained from patient biopsies or glioma cell lines do not show significant constitutive NF\u2010\u03baB activation, unless exposed to inflammatory cytokines. This does not change when gliomas are implanted into the cerebrum of severe combined immundeficient mice. Nevertheless, sulfasalazine but not its cleaved form 5\u2010ASA caused a dose\u2010dependent inhibition of glioma growth. This effect was entirely attributable to the inhibition of cystine uptake via the system x<jats:sub>c<\/jats:sub><jats:sup>\u2212<\/jats:sup> cystine\u2013glutamate transporter. It could be mimicked by S\u20104\u2010carboxy\u2010phenylglycine (S\u20104\u2010CPG) a more specific system x<jats:sub>c<\/jats:sub><jats:sup>\u2212<\/jats:sup> inhibitor, and lentiviral expression of a constitutively active form of I\u03baB kinase b was unable to overcome the growth retarding effects of sulfasalazine or S\u20104\u2010CPG. Both drugs inhibited cystine uptake causing a chronic depletion of intracellular GSH and consequently compromised cellular redox defense which stymied tumor growth. This data suggests that system x<jats:sub>c<\/jats:sub><jats:sup>\u2212<\/jats:sup> is a promising therapeutic target in gliomas and possibly other cancers and that it can be pharmacologically inhibited by Sulfasalazine, an FDA\u2010approved drug.<\/jats:p>","DOI":"10.1111\/j.1471-4159.2009.06129.x","type":"journal-article","created":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T15:24:54Z","timestamp":1241018694000},"page":"182-193","source":"Crossref","is-referenced-by-count":75,"title":["Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor\u2010\u03baB"],"prefix":"10.1111","volume":"110","author":[{"given":"W. Joon","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Sontheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.1149"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004240100537"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006426917654"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/45.1.7"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.414"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(88)90162-6"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5258-04.2005"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(00)00067-8"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20508"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.37.26448"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209841"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/35092578"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402238"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.01.020"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198600321-00005"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04870"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(03)00358-7"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(01)00338-8"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri910"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702937"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604485"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21366"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2034"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5339.860"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.96.5.0909"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1588"},{"key":"e_1_2_7_28_1","first-page":"4571","article-title":"Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells","volume":"23","author":"Narang V. S.","year":"2003","journal-title":"Anticancer Res."},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.5.1342"},{"key":"e_1_2_7_30_1","first-page":"911","article-title":"The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro\u2010Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna","volume":"114","author":"Oberndorfer S.","year":"2002","journal-title":"Wien. Klin. Wochenschr."},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/64.6.479"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197312202892519"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.807"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0392"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022106910017"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(87)90177-9"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.17.11455"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-08-03394.2003"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2003.08.007"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05301.x"},{"key":"e_1_2_7_41_1","first-page":"4871","article-title":"Use of chlorotoxin for targeting of primary brain tumors","volume":"58","author":"Soroceanu L.","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0901-1010"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI992"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(02)00058-9"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700123"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.19458"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1113319"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/134.3.489"},{"key":"e_1_2_7_49_1","first-page":"4383","article-title":"Glioma cells release excitotoxic concentrations of glutamate","volume":"59","author":"Ye Z. C.","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-24-10767.1999"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2009.06129.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2009.06129.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T09:07:39Z","timestamp":1697360859000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2009.06129.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,15]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1471-4159.2009.06129.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06129.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,15]]}}}